Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H16N4O3 |
Molecular Weight | 288.3018 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 2 |
SHOW SMILES / InChI
SMILES
O\N=C\C1=CC=[N+](COC[N+]2=CC=C(C=C2)\C=N\O)C=C1
InChI
InChIKey=HIGRLDNHDGYWQJ-UHFFFAOYSA-P
InChI=1S/C14H14N4O3/c19-15-9-13-1-5-17(6-2-13)11-21-12-18-7-3-14(4-8-18)10-16-20/h1-10H,11-12H2/p+2
Molecular Formula | C14H14N4O3 |
Molecular Weight | 286.286 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Obidoxime is an antidote for organophosphorous nerve agent poisoning including chlorosarin, cyclosarin (GF), R-33 (VR), R-VX, sarin (GB), tabun (GA), VX, chlorosoman, soman (GD), and organophosphorous pesticides. It acts as an acetylcholinesterase (AChE) reactivator. In combination with atropine obidoxime can be used to treat super toxic organophosphate poisoning by relieving the symptoms of skeletal neuromuscular blocking that occurs during a cholinergic crisis.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P22303|||Q53F46 Gene ID: 43.0 Gene Symbol: ACHE Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20208964 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:31:25 GMT 2023
by
admin
on
Fri Dec 15 17:31:25 GMT 2023
|
Record UNII |
N6KNE1QA9O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66880
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
||
|
WHO-VATC |
QV03AB13
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
||
|
WHO-ATC |
V03AB13
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB14676MIG
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
OBIDOXIME
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
DB13750
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
7683-36-5
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
DTXSID50227649
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
100000080007
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
4676
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
8251
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
N6KNE1QA9O
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
C84023
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | |||
|
42826
Created by
admin on Fri Dec 15 17:31:25 GMT 2023 , Edited by admin on Fri Dec 15 17:31:25 GMT 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |